Impact of Pharmaceutical Care on Quality of Life among Chronic Kidney Disease Patients on Hemodialysis
Not Applicable
- Conditions
- Health Condition 1: null- Chronic Kidney disease patients on Hemodialysis
- Registration Number
- CTRI/2014/08/004900
- Lead Sponsor
- Manipal University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
CKD patients on hemodialysis who are in the outpatient category
Patients who are on hemodialysis at least for last 3 months
The patients with a history of regular visits for hemodialysis
ï??Age bracket from 18-75 years
Exclusion Criteria
Patients who are not willing to participate in the study
Patients with psychiatric illness history
Pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Health Related Quality of Life as per the Kidney Disease Quality of Life among CKD patients on Hemodialysis in interventional group and control group for 12 months.Timepoint: 0, 06, 12 months
- Secondary Outcome Measures
Name Time Method Secondary outcomes includes: Measurement and evaluation of medication adherence, hospitalization rates, morality rate, Intra-dialytic weight gain, Blood pressure, complications and Cost of the medications.Timepoint: 0, 06, 12 months